To investigate whether the FV and UP treatment could modulate the protein expression of periostin, a well-known maker of AD [15,16,17,18], the analysis was performed by a specific immunoassay (ELISA) targeting periostin. This evidence concerns the gene POSTN and Alzheimer disease.